Standpoint Research Downgrades Zimmer Holdings (ZMH) to Hold; See Near-Term Top

FREE Breaking News Alerts from StreetInsider.com!

ZMH Hot Sheet

Rating Summary:
9 Buy, 12 Hold, 2 Sell

Rating Trend:

Up

Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23

Standpoint Research downgraded Zimmer Holdings (NYSE: ZMH) from Buy to Hold.

Analyst, Ronnie Moas, said, "Zimmer shares are up 6% this morning on a well-received earnings announcement and hit our price target. ZMH has had a nice move since December 19...up 30% and + 1500 bps versus the S&P-500 and that is significant for a low beta name...this may be a near-term top on an absolute and relative basis. In my opinion it will not be before 2013 that we see a $70 quote on these (now) fairly valued shares (for the first time since Q4 2008)."

"We got very aggressive on this medical equipment industry back in August. We added Medtronic (NYSE: MDT), Stryker (NYSE: SYK and ZMH. We then added Baxter (NYSE: BAX) in January to replace MDT that was dropped in December. We remain with open recommendations out on SYK and BAX – both of those names reported well-received quarters this week. Additionally, we remain with an open outstanding recommendation on Hologic (Nasdaaq: HOLX) (from a couple of years ago)."

For an analyst ratings summary and ratings history on Zimmer Holdings click here. For more ratings news on Zimmer Holdings click here.

Shares of Zimmer Holdings closed at $57.75 yesterday, with a 52 week range of $47.00-$69.93.

Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!